Happy Holiday to you.
Fibonacci Elliott Wave picture for VBIV
(double click the chart to enlarge details)
This is the picture of a combination Elliott wave and Fibonacci price target pattern.
Its a bit complex for those who dont study Fibonacci or Elliott wave. but I like the way this combination works well together.
It looks like the VBIV chart has broken into a new, extended pattern. There was always the possibility that it could stretch above the first major target zone (1.05) and it did. The pullback low at 88 cents was a one time chance to buy the pullback, it was a shallow retrace. which had more central target zone (50%Fib) around 75 cents.
Now it continued to the next target zone and broke thru the 200ma, and looks strong. it has entered into the next higher level wave pattern. and has finish target looking at 2 dollar area now. The peak at 1.40 which got hammered down, was a strong sell off, because that zone was a strong resistance target area for the older pattern. its interesting now to watch , the volatile playing field can gyrate some more here above 1.10 on its way to higher targets at 1.55/1.75 etc, on the way to the finish Fib target area 2 dollars.
Now watch to see if the 200ma will become a big support step at 1.10 area. This is a good rally pattern happening for VBIV investors and traders. Too late for me to try and get in, but happy for you. and those who got the 50 cent bottom.
--------------------------------------------------------
Recent VBIV News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:05:34 PM
- VBI Vaccines Provides an Update on its Restructuring Proceedings • Business Wire • 08/02/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 02:28:18 PM
- VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives • Business Wire • 07/30/2024 01:55:00 PM
- VBI Vaccines Announces Results of Annual General Meeting • Business Wire • 06/25/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 12:00:20 PM
- VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients • Business Wire • 05/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 09:00:33 PM
- VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients • Business Wire • 05/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:18:29 PM
- VBI Vaccines Reports First Quarter 2024 Financial Results • Business Wire • 05/15/2024 08:00:00 PM
- VBI Vaccines Reports Full Year 2023 Financial Results • Business Wire • 04/16/2024 12:00:00 PM
- VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • Business Wire • 04/11/2024 08:05:00 PM
- VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • Business Wire • 04/09/2024 06:45:00 PM
- VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma • Business Wire • 04/03/2024 12:00:00 PM
- VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform • Business Wire • 04/02/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 01:34:40 PM
- VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences • Business Wire • 02/14/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:23:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:15:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:15:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 01:00:27 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM